loading page

Designing, refining and reflecting on 3 years of daily evidence surveillance for Australia's living national COVID-19 guidelines
  • Steve McDonald,
  • Tari Turner
Steve McDonald
Monash University School of Public Health and Preventive Medicine

Corresponding Author:[email protected]

Author Profile
Tari Turner
Monash University
Author Profile


Australia’s national living guidelines for COVID-19 were launched in April 2020 and include over 200 recommendations to guide the clinical care of patients with COVID-19. Until the guidelines were retired in August 2023, new evidence was continually monitored through daily surveillance. This paper describes how evidence surveillance was established (at a time when efforts to collate information on the novel coronavirus were in their infancy and often duplicative) and how it evolved throughout the pandemic. Among the wide range of sources monitored, the collections of COVID-19 research from leading medical journals, medRxiv preprints and PubMed auto alerts proved the most enduring in identifying time-critical and impactful evidence. The paper also explores how evidence was tracked and surveillance integrated into the overall evidence workflow by using messaging apps and communication platforms. Several factors contributed to the feasibility of daily surveillance, including the clearly defined scope of the guidelines; focusing efforts on maximum impact; minimising duplication by partnering with others; setting up simple but effective processes for managing evidence; and the value of continuous involvement of personnel from the outset. The example of Australia’s living COVID-19 guidelines has demonstrated the feasibility and essential role of daily evidence surveillance in maintaining COVID-19 living guidelines for over 3 years.
14 Nov 2023Submitted to Cochrane Evidence Synthesis and Methods
14 Nov 2023Assigned to Editor
14 Nov 2023Submission Checks Completed
20 Nov 2023Reviewer(s) Assigned